Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lantern Pharma Inc. | 429,286 | reported | 24 May 2024 | tx 12+95,779−271,127 |
| COGNITION THERAPEUTICS INC | 56,229 | reported | 19 Sept 2025 | tx 39+5,855,574−11,511,782.28 |
| TFF Pharmaceuticals, Inc. | 33,475 | reported | 29 Dec 2022 | tx 19+917,697−43,919 |
| ACTUATE THERAPEUTICS, INC. | 15,000 | reported | 21 May 2026 | tx 2+30,000 |
| Cue Biopharma, Inc. | 10,000 | reported | 03 Jan 2023 | tx 11+1,042,048 |
| KANA SOFTWARE INC | 9,873 | reported | 31 Dec 2021 | tx 14+11,236−1,363 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 19 Sept 2025 | EXERCISE | COGNITION THERAPEUTICS INC | 7,729 | 0.84 USD | |
| 19 Sept 2025 | EXERCISE | COGNITION THERAPEUTICS INC | 7,729 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 24 May 2024 | SALE | Lantern Pharma Inc. | 4,253 | 6.33 USD | |
| 23 May 2024 | SALE | Lantern Pharma Inc. | 930 | 6.25 USD | |
| 23 May 2024 | SALE | Lantern Pharma Inc. | 2,126 | 6.25 USD | |
| 24 May 2024 | SALE | Lantern Pharma Inc. | 13,888 | 6.33 USD | |
| 23 May 2024 | SALE | Lantern Pharma Inc. | 6,944 | 6.25 USD | |
| 24 May 2024 | SALE | Lantern Pharma Inc. | 1,859 | 6.33 USD | |
| 29 Nov 2023 | SALE | Lantern Pharma Inc. | 53,640 | 3.44 USD | |
| 29 Nov 2023 | SALE | Lantern Pharma Inc. | 91,708 | 3.44 USD | |
| 08 Nov 2023 | GRANT_AWARD | COGNITION THERAPEUTICS INC | 500,095 | 1.05 USD | |
| 03 Jan 2023 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 29 Dec 2022 | GRANT_AWARD | TFF Pharmaceuticals, Inc. | 33,475 | 0.00 USD | deriv |
| 22 Nov 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 43,470 | 1.15 USD | |
| 22 Nov 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 21,735 | 0.00 USD | deriv |
| 10 Jun 2022 | OTHER | COGNITION THERAPEUTICS INC | 2,469 | 0.00 USD | deriv |
| 10 Jun 2022 | OTHER | COGNITION THERAPEUTICS INC | 2,469 | 0.00 USD | deriv |
| 10 Jun 2022 | OTHER | COGNITION THERAPEUTICS INC | 8,335 | 0.00 USD | deriv |
| 23 May 2022 | PURCHASE | Cue Biopharma, Inc. | 150,000 | 3.52 USD | |
| 24 May 2022 | PURCHASE | Cue Biopharma, Inc. | 55,000 | 3.34 USD | |
| 17 May 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 24,600 | 5.08 USD | |
| 16 May 2022 | PURCHASE | TFF Pharmaceuticals, Inc. | 85,000 | 4.86 USD | |
| 31 Mar 2022 | PURCHASE | Cue Biopharma, Inc. | 735,000 | 4.76 USD |